GreyBrook logotype
Investor Login Contact Us

Changing the Lives of More than 20,000 Patients, 2021 Was A Year of Continued Growth for Greenbrook TMS

December 31, 2021

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook and firm’s CEO, Bill Leonard, with 149 centres across the U.S. The company has provided nearly 1,000,000 treatments changing the lives of more than 20,000 patients and has achieved phenomenal growth over the past year through clinic acquisitions, and expansions into new therapies and treatment methods.

Greenbrook TMS was founded with the belief that mental health care as it then existed was failing too many people. Only 49% of patients respond to their first-round antidepressant medication. The other 51% endured lengthy cycles of medication trial-and-error with little improvement, often experiencing side effects like weight gain and sexual dysfunction which worsened their depression symptoms. We knew there had to be a better way.

In 2011, Greenbrook TMS opened its first location in Tysons Corner, Virginia, with a vision to bring together the best care teams and technology into a more personalized, more accessible, and most importantly more effective treatment experience.

Today, more than 10 years after launching that first centre, Greenbrook has provided nearly 1,000,000 treatments and changed the lives of more than 20,000 patients. “We have the largest clinical data set in the U.S., and our TMS patients experience a 62% response rate which is well above the current antidepressant medication therapy rates and that is for patients who have already failed other treatments”, explained Bill Leonard, CEO Greenbrook TMS. “Many of our patients achieve full remission from their depression symptoms—all with little to no side effects”.  With more than 40% growth since 2015, Greenbrook’s 149 centers span 17 states; each location offers state-of-the-art treatment technology in a soothing, spa-like environment, bringing the Greenbrook care experience to more communities. In early 2021, to complement Greenbrook’s deep expertise in depression treatment, the company piloted offering Spravato, a nasal esketamine spray that is FDA-approved for treatment resistant major depressive disorder.

“Our passion has always been fueled by the goal of changing patient’s lives for the better. Looking ahead, as the pandemic continues to disrupt all aspects of daily life, rates of depression continue to soar and the importance of and need for our work is greater than ever. To help meet treatment needs in the community, and building on our successes in 2021, we will expand our Spravato offering to 23 locations by the end of Q1 2022”.

“We are very proud of what the Greenbrook team has accomplished and their commitment to helping so many people. As we expand Greenbrook’s clinical footprint, we are excited to see the impact that TMS and other innovative therapies can have on the lives of patients struggling with mental health”, Elias Vamvakas, Chairman Greenbrook TMS and Chairman Greybrook Capital.

To learn more about Greenbrook TMS, visit


Latest Insights

Greybrook Sponsors and Participates in 2023 Constantine Yorkville Run

September 14, 2023

To date, the Constantine Yorkville Run has helped raise $603,576 for more than 25 local charities. Greybrook is proud to have continued our support as a sponsoring partner and participant in this year’s run, with our own rising to the…

Society Wynwood Continues to See Progress as Neighborhood Transforms   

August 31, 2023

Miami’s vibrant Wynwood neighbourhood is a hub of art, culture, and innovation that continues to grow and evolve with new developments taking shape throughout the area, including our Society Wynwood development located in the heart of the neighbourhood on NW…

Foundations to Framing: Construction Advancing at Archetto Woodbridge Towns

August 27, 2023

Construction has been progressing steadily at our Archetto Towns in Woodbridge. Since our last update, foundations for all 16 blocks have been poured and framing is well underway for many of the homes in the development. The windows and door…

McMichael Estates in Kleinburg Continues to Welcome New Homeowners

August 27, 2023

As of the end of July, 51 out of 75 estate homes have closed, and all estates under construction have been bricked and drywalled and are advancing steadily toward completion with interior finishing. Final closings are set to continue throughout…

Greybrook Proud to be Participating in Upcoming 4th Annual Velo Blu Charity Ride in Support of Blu Genes

August 24, 2023

We look forward to taking part in the 4th Annual Velo Blu Pedal for Blu Genes event on September 15th in Niagara-on-the Lake, along with many of our colleagues and partners in the real estate development, finance, and professional services…

Marlin Spring and Greybrook Launch Marketing Campaign for Queensway I and II

July 31, 2023

The marketing launch for Joya on the Queensway, our mid-rise residential development at 1045 The Queensway, has commenced with email and social media marketing campaigns to generate awareness about the project and invite purchasers and brokers to register.   The 12-storey condominium in the…

Greybrook’s Most Walkable and Well-Connected Condo Developments in Toronto

Portfolio Updates
July 31, 2023

As the City of Toronto grows, welcoming tens of thousands of new residents every year, new condominiums are being planned and constructed throughout the city that offer residents convenient access to area amenities and popular neighbourhoods that can be easily…

Society Atlanta Continues to Reach New Heights in Midtown, Atlanta

Portfolio Updates
July 24, 2023

Vertical construction work continues at our Society Atlanta site, with steady progress resulting in the eighth-floor podium being topped off in May of this year, and concrete pours continuing up to the 15th floor and decking completed on the 16th…

Waterside Villas in Whitby is Fully Occupied

July 20, 2023

The 74-unit townhome development located at Gordon Street and Scadding Avenue saw final home closings completed in Q1 of this year, with all new residents now in their homes in this beautiful waterside community. The remaining scope of work primarily…

Greyspring Apartments Makes its Latest Acquisition in Montreal 

July 19, 2023

In June, Greyspring Apartments announced the acquisition of two 14-storey concrete apartment buildings at 135 and 145-155 Rue Deguire in Montreal, Québec, representing a strategic expansion into the established borough of Saint Laurent located on the Island of Montreal. This…

[geot_filter exclude_country="cn"]All Publications[/geot_filter][geot_filter country="cn"]所有出版物[/geot_filter]

Join our newsletter and keep up to date with our news & insights

Contact us